NeoPharm Will Not Face SEC Charges
Biotech drug maker NeoPharm Inc. announced Friday that the U.S. Securities and Exchange Commission has ended its probe of the company and will not recommend any enforcement action....To view the full article, register now.
Already a subscriber? Click here to view full article